News|Articles|September 18, 2009

Semisolid Formulation Development: The CRO Approach - SP Formulations Whitepaper

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance. Subscribe to Pharmaceutical Technology and never miss an industry breakthrough.

Subscribe

Related Content

CPHI Milan Adds Sustainability Summit and New AI, Cold Chain, and Labeling Zones to 2026 Agenda

BySusan Haigney

August 11th 2026

Three Formats, One Platform: Halo's New Sterile Fill-Finish Line

ByLee Karras,Zachary Zubulake

August 11th 2026

Bristol-Myers Squibb’s new facility is a part of a $40 billion commitment the company pledged to invest in research and development, technology and domestic manufacturing | Image Courtesy of Bristol-Myers Squibb

BMS Bets on Flexible Capacity With $2.3B Texas Campus

ByZachary Zubulake

August 10th 2026

PharmTech Weekly Roundup—August 7, 2026

BySusan Haigney

August 7th 2026

From Warehouse to Lakehouse: A Life Sciences Playbook for Regulated, AI-Ready Data Modernization

ByPartha S. Anbil,Deepak Manjarekar

August 7th 2026

Semisolid Formulation Development: The CRO Approach - SP Formulations Whitepaper

Related Content

CPHI Milan Adds Sustainability Summit and New AI, Cold Chain, and Labeling Zones to 2026 Agenda

Three Formats, One Platform: Halo's New Sterile Fill-Finish Line

BMS Bets on Flexible Capacity With $2.3B Texas Campus

PharmTech Weekly Roundup—August 7, 2026

From Warehouse to Lakehouse: A Life Sciences Playbook for Regulated, AI-Ready Data Modernization

Trending on Pharmaceutical Technology

Pharma's AI ROI Problem Isn't a Tech Problem but a Qualification Problem

Danish Biotechs Attracting Investor Attention

Three Formats, One Platform: Halo's New Sterile Fill-Finish Line

CPHI Milan Adds Sustainability Summit and New AI, Cold Chain, and Labeling Zones to 2026 Agenda

BMS Bets on Flexible Capacity With $2.3B Texas Campus